Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company  | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| DePuy Orthopaedics, Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2013 | private lawsuit-federal | $2,475,000,000 |
| Danske Bank A/S | Danske Bank | financial services | anti-money-laundering deficiencies | 2022 | DOJ_CRIMINAL | $2,000,000,000 |
| Daimler AG | Mercedes-Benz Group | motor vehicles | air pollution violation | 2020 | EPA | $1,500,000,000 |
| CVS | CVS Health | retailing | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $5,000,000,000 |
| Cummins Inc. | Cummins | miscellaneous manufacturing | air pollution violation | 2024 | EPA | $2,000,000,000 |
| Credit Suisse AG | UBS | financial services | tax violations | 2014 | DOJ_TAX | $1,800,000,000 |
| Credit Suisse AG | UBS | financial services | tax violations | 2014 | NY-DFS | $715,000,000 |
| Credit Suisse | UBS | financial services | toxic securities abuses | 2014 | FHFA | $885,000,000 |
| Credit Suisse | UBS | financial services | toxic securities abuses | 2017 | DOJ_CIVIL | $5,280,000,000 |
| CR Intrinsic Investors | investor protection violation | 2013 | SEC | $601,747,463 | ||
| Countrywide Home Loans | Bank of America | financial services | mortgage abuses | 2008 | MULTI-AG | $8,680,000,000 |
| Countrywide Financial Corporation | Bank of America | financial services | mortgage abuses | 2010 | MULTI-AG | $3,004,100,000 |
| Corinthian Colleges, Inc. | consumer protection violation | 2015 | CFPB | $531,224,267 | ||
| Corinthian Colleges, Inc. | consumer protection violation | 2016 | CA-AG | $1,170,025,000 | ||
| ConocoPhillips | Phillips 66 | oil and gas | air pollution violation | 2005 | EPA | $539,500,000 |
| Commerzbank AG | Commerzbank | financial services | economic sanction violation | 2015 | DOJ_CRIMINAL | $642,000,000 |
| Commerzbank | Commerzbank | financial services | economic sanction violation | 2015 | NY-DFS | $610,000,000 |
| Citigroup Inc. | Citigroup | financial services | toxic securities abuses | 2014 | DOJ | $7,000,000,000 |
| Citigroup Inc. | Citigroup | financial services | mortgage abuses | 2012 | DOJ | $2,202,000,000 |
| Citigroup Global Markets, Inc. and Citi Smith Barney | Citigroup | financial services | investor protection violation | 2008 | MULTI-AG | $7,100,000,000 |
| Citigroup | Citigroup | financial services | toxic securities abuses | 2013 | FHFA | $968,000,000 |
| Citicorp | Citigroup | financial services | price-fixing or anti-competitive practices | 2015 | DOJ_CRIMINAL | $925,000,000 |
| Citibank N.A. | Citigroup | financial services | consumer protection violation | 2015 | CFPB | $733,800,000 |
| Citibank | Citigroup | financial services | banking violation | 2013 | OCC | $793,492,868 |
| Cinergy Corporation | Duke Energy | utilities and power generation | air pollution violation | 2000 | EPA | $1,430,000,000 |
| Chemours | Chemours | chemicals | PFAS violation | 2024 | private lawsuit-federal | $592,000,000 |
| Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | FTC | $1,200,000,000 |
| Cardinal Health Inc. | Cardinal Health | wholesalers | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $6,489,000,000 |
| British American Tobacco | British American Tobacco | tobacco | economic sanction violation | 2023 | DOJ_NATSEC | $629,000,000 |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $515,000,000 |
| BP EXPLORATION/MOEX/TRANSOCEAN DEEPWATER/TRITON/GULF OF MEXICO OIL SPILL/DEEPWATER HORIZON (NC) | BP | oil and gas | water pollution violation | 2016 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,377,250,000 |
| BP Exploration and Production Inc. | BP | oil and gas | oil spill | 2012 | DOJ | $4,000,000,000 |
| BP Exploration & Production Inc. (Gulf of Mexico Oil Spill) (National Case) (Lead) | BP | oil and gas | water pollution violation | 2016 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,372,250,000 |
| BP | BP | oil and gas | oil spill | 2015 | DOJ | $20,800,000,000 |
| BP | BP | oil and gas | investor protection violation | 2012 | SEC | $525,000,000 |
| BP | BP | oil and gas | air pollution violation | 2001 | EPA | $660,000,000 |
| BP | BP | oil and gas | oil spill | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,900,000,000 |
| BP | BP | oil and gas | oil spill | 2015 | MS-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,500,000,000 |
| BP | BP | oil and gas | oil spill | 2012 | private lawsuit-federal | $7,800,000,000 |
| Boston Scientific Corp. | Boston Scientific Corp. | medical equipment and supplies | drug or medical equipment safety violation | 2020 | private lawsuit-federal | $915,000,000 |
| Boeing Company | Boeing | aerospace and military contracting | False Claims Act and related | 2006 | DOJ_CIVIL | $615,000,000 |
| Boeing Company | Boeing | aerospace and military contracting | fraud | 2021 | DOJ_CRIMINAL | $2,513,600,000 |
| Boehringer Ingelheim International | Boehringer Ingelheim | pharmaceuticals | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $650,000,000 |
| BNP Paribas S.A. | BNP Paribas | financial services | economic sanction violation | 2015 | DOJ_CRIMINAL | $8,973,600,000 |
| BNP Paribas S.A. | BNP Paribas | financial services | economic sanction violation | 2014 | NY-MANDA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,243,400,000 |
| BNP Paribas | BNP Paribas | financial services | economic sanction violation | 2014 | NY-DFS | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,240,000,000 |
| Blue Cross Blue Shield Association | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $2,670,000,000 | ||
| Biogen Inc. | Biogen | pharmaceuticals | False Claims Act and related | 2022 | DOJ_CIVIL | $900,000,000 |
| Binance Holdings, Ltd | Binance Holdings | financial services | economic sanction violation | 2023 | OFAC | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $968,618,825 |
| Binance Holdings Limited, | Binance Holdings | financial services | anti-money-laundering deficiencies | 2023 | FINCEN | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,400,000,000 |
| Binance Holdings Limited et al. | Binance Holdings | financial services | investor protection violation | 2023 | CFTC | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,700,000,000 |
| Binance Holdings Limited | Binance Holdings | financial services | anti-money-laundering deficiencies | 2023 | DOJ_NATSEC | $4,316,126,163 |
| Bayer AG | Bayer | chemicals | drug or medical equipment safety violation | 2020 | private lawsuit-state | $1,600,000,000 |
| Bayer AG | Bayer | chemicals | product safety violation | 2011 | private lawsuit-federal | $750,000,000 |
| Bayer | Bayer | chemicals | product safety violation | 2020 | private lawsuit-federal | $9,600,000,000 |
| Barclays PLC | Barclays | financial services | price-fixing or anti-competitive practices | 2015 | DOJ_CRIMINAL | $710,000,000 |
| Barclays Capital, Inc. | Barclays | financial services | toxic securities abuses | 2018 | USAO | $2,000,000,000 |
| Bank of New York Mellon | Bank of New York Mellon | financial services | banking violation | 2015 | USAO | $714,000,000 |
| Bank of America, N.A. | Bank of America | financial services | consumer protection violation | 2014 | CFPB | $747,000,000 |
| Bank of America N.A. | Bank of America | financial services | consumer protection violation | 2018 | private lawsuit-federal | $1,266,600,000 |
| Bank of America Corporation | Bank of America | financial services | mortgage abuses | 2014 | DOJ | $16,650,000,000 |
| Bank of America Corporation | Bank of America | financial services | mortgage abuses | 2012 | DOJ | $10,956,600,000 |
| Bank of America Corporation | Bank of America | financial services | toxic securities abuses | 2014 | FHFA | $9,300,000,000 |
| Bank of America Corporation | Bank of America | financial services | mortgage abuses | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $943,000,000 |
| Bank of America | Bank of America | financial services | banking violation | 2013 | OCC | $2,886,578,478 |
| Bank of America | Bank of America | financial services | toxic securities abuses | 2011 | FHFA | $1,300,000,000 |
| Bank of America | Bank of America | financial services | toxic securities abuses | 2011 | FHFA | $1,520,000,000 |
| Bank of America | Bank of America | financial services | toxic securities abuses | 2013 | FHFA | $10,350,000,000 |
| Bank of America | Bank of America | financial services | investor protection violation | 2012 | MULTI-AG | $2,430,000,000 |
| Bank of America | Bank of America | financial services | mortgage abuses | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,382,415,075 |
| Bank Julius Baer & Co. Ltd. | Julius Baer Group | financial services | tax violations | 2016 | DOJ_TAX | $547,000,000 |
| Bank Hapoalim B.M. and Bank Hapoalim (Switzerland) Ltd. | Bank Hapoalim | financial services | tax violations | 2020 | DOJ_TAX | $616,910,000 |
| Banc of America Securities LLC | Bank of America | financial services | investor protection violation | 2008 | MULTI-AG | $4,550,000,000 |
| AstraZeneca LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $520,000,000 |
| Anadarko Petroleum Corp. | Occidental Petroleum | oil and gas | environmental violation | 2015 | EPA | $5,150,000,000 |
| Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $762,000,000 |
| Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $612,000,000 |
| AmerisourceBergen Corporation | AmerisourceBergen | wholesalers | False Claims Act and related | 2018 | DOJ_CIVIL | $625,000,000 |
| AmerisourceBergen Corporation | AmerisourceBergen | wholesalers | off-label or unapproved promotion of medical products | 2021 | MULTI-AG | $6,510,000,000 |
| American International Group, Inc. | American International Group | financial services | investor protection violation | 2006 | SEC | $800,000,000 |
| American International Group | American International Group | financial services | price-fixing or anti-competitive practices | 2006 | NY-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,619,000,000 |
| American International Group | American International Group | financial services | investor protection violation | 2010 | OH-AG | $725,000,000 |
| American Honda Motor Co. | Honda | motor vehicles | product safety violation | 2018 | private lawsuit-federal | $605,000,000 |
| American Home Products | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2002 | private lawsuit-federal | $3,750,000,000 |
| American Electric Power | American Electric Power | utilities and power generation | air pollution violation | 2007 | EPA | $4,675,000,000 |
| American Electric Power | American Electric Power | utilities and power generation | environmental violation | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,675,000,000 |
| Alstom S.A. | Alstom | miscellaneous energy products and systems | Foreign Corrupt Practices Act | 2015 | DOJ_CRIMINAL | $772,290,000 |
| Allianz Global Investors U.S. LLC | Allianz | financial services | investor protection violation | 2022 | SEC | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,024,200,000 |
| Allianz Global Investors U.S. LLC | Allianz | financial services | investor protection violation | 2022 | USAO | $5,763,000,000 |
| Alliance Capital Management | Equitable Holdings | financial services | investor protection violation | 2003 | NY-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $600,000,000 |
| Allergan Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $600,000,000 |
| Allergan | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $2,370,000,000 |
| Airbus SE | Airbus | aerospace and military contracting | export control violation | 2020 | DOJ_CRIMINAL | $527,224,475 |
| Adelphia Communications Corporation | accounting fraud or deficiencies | 2005 | DOJ_CRIMINAL | $715,000,000 | ||
| Abbott Laboratories Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $1,500,000,000 |
| Abbott Laboratories and CG Nutritionals | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $600,000,000 |
| 3M Company | 3M Company | miscellaneous manufacturing | product safety violation | 2023 | private lawsuit-federal | $6,000,000,000 |
| 3M Company | 3M Company | miscellaneous manufacturing | PFAS violation | 2024 | private lawsuit-federal | $12,500,000,000 |
| 3M | 3M Company | miscellaneous manufacturing | PFAS violation | 2018 | MN-AG | $850,000,000 |
